2020 Agenda is now available!
The Cell & Gene Meeting on the Med features expert-led panels, in-depth keynote speeches, interactive fireside chats, and 50+ presentations by leading publicly traded and privately held companies from around the globe.
7:45am – 8:45am | REGISTRATION
8:45am | GENERAL SESSION AND PARTNERING OPENS
WELCOME AND STATE OF THE INDUSTRY REMARKS {Gaudi 3}
Speaker:
Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine (ARM)
KEYNOTE ADDRESS & FIRESIDE CHAT {Gaudi 3}
Speaker:
Guido Rasi, M.D., Director General, European Medicines Agency (EMA)
Fireside Chat With:
Miguel Forte, M.D., Ph.D., CEO of Bone Therapeutics
PLENARY SESSION: LESSONS LEARNED FROM COMMERCIAL PIONEERS {Gaudi 3}
Speakers:
Lisa Deschamps, SVP and Chief Business Officer, AveXis
Alison Finger, Chief Commercial Officer, bluebird bio
Robin Kenselaar, SVP & General Manager EMEA, Orchard Therapeutics
10:45am – 11:15am | MORNING BREAK
11:15am – 12:30pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 3}
COMPANY PRESENTATIONS {Gaudi 3}
12:30pm – 1:45pm | LUNCH
Sponsored by Covance
1:45pm – 3:30pm | CONCURRENT TRACKS
PANEL: HOSPITAL EXEMPTION: IMPLICATIONS FOR PATIENTS AND INNOVATION {Gaudi 3}
1:45pm – 2:45pm
COMPANY PRESENTATIONS {Gaudi 2}
COMPANY PRESENTATIONS {Gaudi 3}
COMPANY PRESENTATIONS {Gaudi 2}
3:30pm – 4:00pm | AFTERNOON BREAK
4:00pm – 5:00pm | CONCURRENT TRACKS
PANEL: CELL AND GENE THERAPIES FOR CHRONIC CONDITIONS {Gaudi 3}
4:00pm – 5:00pm
COMPANY PRESENTATIONS {Gaudi 2}
5:00pm | PARTNERING CLOSES
6:00pm – 9:00pm | NETWORKING BASH
7:30am – 8:30am | REGISTRATION
8:30am | GENERAL SESSION AND PARTNERING OPENS
WELCOME REMARKS {Gaudi 3}
Speaker:
Matthew Patterson, Strategic Advisor, Audentes Therapeutics, An Astellas Company; Chairman, Alliance for Regenerative Medicine (ARM)
8:45am – 10:45am | CONCURRENT TRACKS
PANEL: THE NEXT WAVE OF COMMERCIAL DEVELOPMENT {Gaudi 3}
8:45am – 9:45am
COMPANY PRESENTATIONS {Gaudi 2}
SPOTLIGHT SESSION: PATIENT-FOCUSED TOPIC {Gaudi 3}
9:45am – 10:15am
COMPANY PRESENTATIONS {Gaudi 2}
FIRESIDE CHAT: DISCUSSION WITH GERMAN MARKET ACCESS POLICYMAKER {Gaudi 3}
10:15am – 10:45am
COMPANY PRESENTATIONS {Gaudi 2}
10:45am – 11:15am | MORNING BREAK
11:15am – 12:30pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 3}
COMPANY PRESENTATIONS {Gaudi 2}
12:30pm – 1:45pm | LUNCH
Sponsored by Polyplus-Transfection
1:45pm – 3:00pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 2}
PANEL: DISRUPTIVE TECHNOLOGIES THAT WILL CHANGE THE CELL THERAPY LANDSCAPE {Gaudi 3}
2:15pm – 3:00pm
COMPANY PRESENTATIONS {Gaudi 2}
3:00pm – 3:30pm | AFTERNOON BREAK
3:30pm – 5:00pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 2}
PANEL & CLOSING REMARKS: THE STATE OF MONEY {Gaudi 3}
Chair:
Matthew Durdy, Chief Executive of the Cell and Gene Therapy Catapult
Speaker:
Dmitry Kuzmin, Ph.D., Managing Partner, 4BIO Capital
5:00pm | PARTNERING CLOSES
6:00pm – 8:00pm | WINE TASTING AND RECEPTION
Sponsored by Dark Horse Consulting
8:00am – 11:00am | ARM EU COMMITTEE MEETINGS
Open to ARM Members Only
